American Century Companies’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-50,947
| Closed | -$298K | – | 2987 |
|
|
2025
Q1 | $298K | Buy |
50,947
+13,906
| +38% | +$73.3K | ﹤0.01% | 2669 |
|
|
2024
Q4 | $138K | Buy |
37,041
+4,224
| +13% | +$19.5K | ﹤0.01% | 2816 |
|
|
2024
Q3 | $183K | Buy |
32,817
+5,806
| +21% | +$40.6K | ﹤0.01% | 2772 |
|
|
2024
Q2 | $227K | Buy |
27,011
+1,907
| +8% | +$20.3K | ﹤0.01% | 2702 |
|
|
2024
Q1 | $363K | Buy |
25,104
+7,920
| +46% | +$131K | ﹤0.01% | 2562 |
|
|
2023
Q4 | $370K | Buy |
+17,184
| New | +$307K | ﹤0.01% | 2479 |
|
|
2022
Q2 | – | Sell |
-3,618
| Closed | -$260K | – | 2395 |
|
|
2022
Q1 | $260K | Sell |
3,618
-344
| -9% | -$24.8K | ﹤0.01% | 2112 |
|
|
2021
Q4 | $321K | Hold |
3,962
| – | – | ﹤0.01% | 2084 |
|
|
2021
Q3 | $461K | Sell |
3,962
-15
| -0.4% | -$1.96K | ﹤0.01% | 1908 |
|
|
2021
Q2 | $659K | Hold |
3,977
| – | – | ﹤0.01% | 1730 |
|
|
2021
Q1 | $555K | Hold |
3,977
| – | – | ﹤0.01% | 1687 |
|
|
2020
Q4 | $688K | Buy |
3,977
+9
| +0.2% | +$1.46K | ﹤0.01% | 1418 |
|
|
2020
Q3 | $553K | Sell |
3,968
-672
| -14% | -$89.8K | ﹤0.01% | 1311 |
|
|
2020
Q2 | $554K | Sell |
4,640
-10,991
| -70% | -$1.3M | ﹤0.01% | 1256 |
|
|
2020
Q1 | $1.56M | Buy |
+15,631
| New | +$1.88M | ﹤0.01% | 897 |
|
|
2018
Q3 | – | Sell |
-90,195
| Closed | -$7.2M | – | 1375 |
|
|
2018
Q2 | $7.2M | Sell |
90,195
-10,477
| -10% | -$869K | 0.01% | 750 |
|
|
2018
Q1 | $8.72M | Buy |
100,672
+19,818
| +25% | +$1.6M | 0.01% | 675 |
|
|
2017
Q4 | $5.58M | Buy |
80,854
+27,078
| +50% | +$2.17M | 0.01% | 822 |
|
|
2017
Q3 | $4.89M | Sell |
53,776
-533,659
| -91% | -$45.7M | ﹤0.01% | 856 |
|
|
2017
Q2 | $43.7M | Sell |
587,435
-101,000
| -15% | -$8.09M | 0.05% | 392 |
|
|
2017
Q1 | $64.5M | Sell |
688,435
-74,292
| -10% | -$6.73M | 0.07% | 329 |
|
|
2016
Q4 | $55.4M | Buy |
762,727
+324,291
| +74% | +$27.8M | 0.06% | 359 |
|
|
2016
Q3 | $45.8M | Buy |
438,436
+195,252
| +80% | +$17.6M | 0.05% | 377 |
|
|
2016
Q2 | $17.9M | Buy |
243,184
+164,505
| +209% | +$11.2M | 0.02% | 544 |
|
|
2016
Q1 | $4.43M | Sell |
78,679
-5,091
| -6% | -$300K | 0.01% | 847 |
|
|
2015
Q4 | $5.66M | Sell |
83,770
-12,007
| -13% | -$643K | 0.01% | 800 |
|
|
2015
Q3 | $4.44M | Buy |
95,777
+30,089
| +46% | +$1.46M | 0.01% | 858 |
|
|
2015
Q2 | $3.53M | Buy |
+65,688
| New | +$3.35M | ﹤0.01% | 940 |
|
Other funds holding NVRO
American Century Companies's NVRO Position: Q2 2025 in Review
American Century Companies sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 50,947 shares — an estimated $298K sold.
American Century Companies first reported a position in NVRO in Q2 2015 and held it in 28 quarters. The position peaked at $64.5M in Q1 2017. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- American Century Companies reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- American Century Companies sold 50,947 NEVRO CORP. shares in Q2 2025, an estimated $298K.
- American Century Companies first reported a position in NEVRO CORP. in Q2 2015 and held it in 28 quarters.
- American Century Companies's NEVRO CORP. position peaked at $64.5M in Q1 2017.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on American Century Companies's 13F filing for Q2 2025, filed 12 Aug 2025.